Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Clinical trial NCT04309084 · UNKNOWN

Trial details

NCT number: NCT04309084
Sponsor: Celularity Incorporated
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma Neoplasm, Plasma Cell Neoplasms by Histologic Type Neoplasms Hemostatic Disorder Vascular Diseases Cardiovascular Diseases Paraproteinemias Blood Protein Disorders Hematologic Diseases Hemorrhagic Disorders Lymphoproliferative Disorders

Start date: 2020-05-12
Primary completion: 2023-01-31
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.